Skip to main navigation Skip to search Skip to main content

NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway

  • Masaki Terabe
  • , So Matsui
  • , Nancy Noben-Trauth
  • , Hangjiong Chen
  • , Cynthia Watson
  • , Debra D. Donaldson
  • , David P. Carbone
  • , William E. Paul
  • , Jay A. Berzofskv

Research output: Contribution to journal › Article › peer-review

Abstract

Using a mouse model in which tumors show a growth-regression-recurrence pattern, we investigated the mechanisms for down-regulation of cytotoxic T lymphocyte-mediated tumor immunosurveillance. We found that interleukin 4 receptor (IL-4R) knockout and downstream signal transducer and activator of transcription 6 (STAT6) knockout, but not IL-4 knockout, mice resisted tumor recurrence, which implicated IL-13, the only other cytokine that uses the IL-4R-STAT6 pathway. We confirmed this by IL-13 inhibitor (sIL-13Rα2-Fc) treatment. Loss of natural killer T cells (NKT cells) in CD1 knockout mice resulted in decreased IL-13 production and resistance to recurrence. Thus, NKT cells and IL-13, possibly produced by NKT cells and signaling through the IL-4R-STAT6 pathway, are necessary for down-regulation of tumor immunosurveillance. IL-13 inhibitors may prove to be a useful tool in cancer immunotherapy.

Original languageEnglish
Pages (from-to)515-520
Number of pages6
JournalNature Immunology
Volume1
Issue number6
DOIs
StatePublished - Dec 2000

Fingerprint

Dive into the research topics of 'NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway'. Together they form a unique fingerprint.

Cite this